China's Communist Party just purged its third sitting Politburo member — and the regime that controls America's supply chain and pharmaceutical manufacturing keeps eating its own.
Ma Xingrui, former member of the CCP's 24-person Politburo and until recently the party chief of Xinjiang, was expelled Tuesday on a laundry list of corruption charges, state media reported. The charges include "power-for-sex" deals, accepting huge sums of money and property, arranging jobs for associates, and what authorities described as large-scale "family corruption" — relatives leveraging his official influence for personal gain. Xinhua did not specify the amounts involved, and Ma could not be reached for comment, Reuters reported.
This is the third sitting Politburo member purged since 2025. The other two were military generals: He Weidong, former vice chair of the Central Military Commission, expelled last October, and Zhang Youxia, the military's most senior general, who came under investigation in January. Analysts have long noted that Xi Jinping's anti-corruption campaign serves as much to enforce personal loyalty as to clean house — a detail the Associated Press reported but that Washington's China-engagement crowd prefers to sidestep.
Ma's portfolio matters to Americans. Before running Xinjiang — the region infamous for its internment camps — Ma was governor of Guangdong, the manufacturing powerhouse bordering Hong Kong that anchors so much of what ends up on American shelves. An aerospace engineer by training, he was exactly the kind of technocrat U.S. executives and lobbyists point to when they argue Beijing is run by competent pragmatists rather than paranoid autocrats. He also served as deputy head of the central rural work leading group, Reuters reported.
The pattern is clear. Xi consolidates power by purging rivals and lieutenants alike under the banner of anti-corruption, and the institutions American businesses depend on — provincial governments, military command, party leadership — rotate through a cycle of loyalty tests and public ruin. No amount of corporate lobbying changes the nature of this regime. Every factory order, every pharmaceutical ingredient sourced from China, runs through a system where the rules are written by one man and enforced by destroying anyone who falls out of favor.
Washington keeps betting the supply chain on a house that keeps purging its own. The question isn't whether Beijing is corrupt — it's why American policymakers still refuse to demand an exit strategy.
